|ARCA biopharma, Inc.|
11080 CirclePoint Road
United States - Map
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. The company has a collaboration agreement with Medtronic, Inc. for the support of Gencaros Phase IIB/III clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
|Dr. Michael R. Bristow M.D., Ph.D.,
Co-Founder, Chief Exec. Officer, Pres and Director
|Mr. Christopher D. Ozeroff ,
Sr. VP, Gen. Counsel and Sec.
|Mr. Brian L. Selby ,
Chief Accounting Officer and VP of Fin.
|Mr. Thomas A. Keuer ,
Chief Operating Officer
|Mr. Derek K. Cole ,
VP of Investor Relations and Corp. Communications
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|